Amphivena Therapeutics, Inc. is a clinical-stage, immuno-oncology company with a novel platform of T cell engagers (Amphivena ReSTORE™) that directly targets myeloid derived suppressor cells (MDSC), thus relieving cancer-induced immune suppression while controlling cytokine release syndrome (CRS).
Member count: 11-50
Total raised: $62M
Founded date: 2012
Investors 3
| Date | Name | Website |
| - | ND CAPITAL | nd.capital |
| - | Korys | korys.be |
| - | Solasta Ve... | solasta-ve... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 24.09.2019 | Series C | $62M | - | finsmes.co... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 16.12.2020 | Amphivena ... | SOUTH SAN FRANCISCO, Calif.,... | - | - | prnewswire... |
| 09.11.2020 | Amphivena ... | SOUTH SAN FRANCISCO, Calif.,... | - | - | prnewswire... |
| 17.12.2019 | Amphivena ... | - | - | - | solasta-ve... |
| 24.09.2019 | Amphivena ... | - | - | - | mpmcapital... |
| 24.09.2019 | Amphivena ... | The company is developing a bi... | - | - | medcitynew... |
| 24.09.2019 | Amphivena ... | - | - | - | embl-ventu... |
| 24.09.2019 | Quiet biot... | Little-known and super quiet b... | Biotech | - | fiercebiot... |
| 24.09.2019 | Quiet biot... | Little-known and super quiet b... | Biotech | - | fiercebiot... |
| 24.09.2019 | Amphivena ... | Amphivena Therapeutics, Inc., ... | USA | - | finsmes.co... |
| - | Amphivena ... | A company developing a bispeci... | - | - | medcitynew... |